Letter: infliximab therapy for patients with inflammatory bowel disease - some unanswered questions. Authors' reply

D. J. Buurman*, J. M. Maurer, R. J. Keizer, J. G. W. Kosterink, G. Dijkstra

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)1134-1134
Number of pages1
JournalAlimentary Pharmacology & Therapeutics
Volume42
Issue number9
DOIs
Publication statusPublished - Nov-2015

Keywords

  • CROHNS-DISEASE
  • CLINICAL-OUTCOMES

Cite this